申请人:Sojournix, Inc.
公开号:US20200216396A1
公开(公告)日:2020-07-09
Disclosed herein are deuterated forms of 2-ethylamino-8-fluoro-3-methyl-1-oxo-1,2-dihydro-isoquinoline-4-carboxylic acid ((S)-cyclopropyl-phenyl-methyl)-amide (also referred to herein as SJB-01) and pharmaceutical compositions comprising such compounds.
本文披露了2-乙基氨基-8-氟-3-甲基-1-氧代-1,2-二氢异喹啉-4-羧酸的氘代形式((S)-环丙基苯甲基)-酰胺(SJB-01),以及包含这些化合物的制药组合物。